KD
Kevin Dai
Managing Director at Vivo Capital
San Francisco Bay Area
Overview
Kevin Dai is the Managing Director at Vivo Capital, with a background in clinical pharmacy, oncology, and integrative oncology. He has previously worked at prestigious institutions such as Memorial Sloan-Kettering Cancer Center and Merck, bringing a wealth of experience in clinical pharmacology and healthcare.
Dai's career highlights include his role as a Clinical Oncology Pharmacy Specialist at Memorial Sloan-Kettering Cancer Center and his current position as Managing Director at Vivo Capital, where he focuses on investing in medical devices, pharmaceuticals, and biotechnology companies in the San Francisco Bay Area.
Work Experience
Managing Director
2015 - Current
Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM
Equity Research Associate - Healthcare/Biotechnology
2014 - 2015
Canaccord Genuity is the global capital markets division of it, offering institutional and corporate clients idea-driven investment banking.
Clinical Oncology Pharmacy Specialist - Hematology/Oncology
2011 - 2014